[NRIX] QoQ Quarter Result on 30-Nov-2022 [#Q4]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
09-Feb-2023
Financial Year
2022
Quarter
30-Nov-2022 [#Q4]
Profit Trend
QoQ- 6.70%
YoY- -10.62%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
31/08/23 31/05/23 28/02/23 30/11/22 31/08/22 31/05/22 28/02/22 CAGR
Revenue 18,467 30,676 12,685 6,783 10,791 11,432 9,621 54.26%
PBT -36,982 -24,277 -40,733 -46,717 -45,709 -45,401 -42,533 -8.87%
Tax 3,424 -2,488 -5,399 -5,010 -1,009 -314 -211 -
NP -36,982 -21,789 -35,334 -41,707 -44,700 -45,087 -42,322 -8.57%
Tax Rate - - - - - - - -
Total Cost 55,449 52,465 48,019 48,490 55,491 56,519 51,943 4.43%
Ratio Analysis
31/08/23 31/05/23 28/02/23 30/11/22 31/08/22 31/05/22 28/02/22 CAGR
NP Margin -200.26 -71.03 -278.55 -614.88 -414.23 -394.39 -439.89 -40.73%
Per Share
31/08/23 31/05/23 28/02/23 30/11/22 31/08/22 31/05/22 28/02/22 CAGR
EPS -0.68 -0.40 -0.65 -0.77 -0.88 -1.00 -0.95 -19.93%
EPS Diluted -0.68 -0.40 -0.65 -0.77 -0.88 -1.00 -0.95 -19.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.